SOLA Biosciences Email Format
Pharmaceutical ManufacturingMassachusetts, United States2-10 Employees
SOLA Biosciences dedicates to develop gene-therapies for patients with neurodegenerative diseases by Engineered Targeting Chaperone Platform Technology (JUMP70) designed to harness the power of a patient’s own chaperones to repair specific disease-causing misfolding proteins.